Back
Tenet Healthcare 10K Form
Buy
56
THC
Tenet Healthcare
Last Price:
$128.03
Seasonality Move:
11.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | THC/Tenet Healthcare Quarterly |
2024-02-16 | 10K | THC/Tenet Healthcare Annual |
2023-10-30 | 10Q | THC/Tenet Healthcare Quarterly |
2023-07-31 | 10Q | THC/Tenet Healthcare Quarterly |
2023-04-28 | 10Q | THC/Tenet Healthcare Quarterly |
2023-02-21 | 10K | THC/Tenet Healthcare Annual |
Receive THC News And Ratings
See the #1 stock for the next 7 days that we like better than THC
THC Financial Statistics
Sales & Book Value
Annual Sales: | $20.7B |
---|---|
Cash Flow: | $-661M |
Price / Cash Flow: | 10.76 |
Annual Sales: | $43.85 |
Price / Book: | 2.8 |
Profitability
EPS (TTM): | 32.23000 |
---|---|
Net Income (TTM): | $3.2B |
Gross Margin: | $17B |
Return on Equity: | 42.47% |
Return on Assets: | 11.05% |
Tenet Healthcare Earnings Forecast
Key Tenet Healthcare Financial Ratios
-
The Gross Profit Margin over the past 39 years for THC is 82.35%.
-
The Selling, General & Administrative Expenses for THC have been equal to 42.59% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 25.81% of Operating Income.
-
The Net Earning history of THC is 15.49% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 22 years.
Tenet Healthcare Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | THC |
CUSIP: | 88033G |
Website: | tenethealth.com |
Debt
Debt-to-Equity Ratio: | 3.16 |
---|---|
Current Ratio: | 1.78 |
Quick Ratio: | 1.54 |
Price-to-Earnings
Trailing P/E Ratio: | 3.75 |
---|---|
Forward P/E Ratio: | 9.29 |
THC Technical Analysis vs Fundamental Analysis
Buy
56
Tenet Healthcare (THC)
is a Buy
Is Tenet Healthcare a Buy or a Sell?
-
Tenet Healthcare stock is rated a BuyThe current Tenet Healthcare [THC] share price is $122.67. The Score for THC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.